Hyundai Heavy Industries (HHI), the world’s largest shipbuilder and a leading medical robot manufacturer, announced today it is successfully testing three types of its proprietary medical robots at Asan Medical Center, Ulsan University Hospital, Chonnam National University Gwangju 2nd Geriatric Hospital and Ulsan Noin Hospital.

At Asan Medical Center where a presentation on “Future Growth Engine Flagship Joint Performance” organized by Ministry of Science, ICT and Future Planning took place, HHI announced that it provided rehabilitation robot MORNING WALK, patient transfer robot CARRBOT and robot system that guides needle path in CT-guided interventional procedure ROBIN at the aforementioned hospitals in March and April this year. HHI will continue the clinical trials to test the efficiency and safety of the robots by 2020.

MORNING WALK, a gait rehabilitation robot that jointly developed with Asan Medical Center, was tested more than 400 times with 60 patients and it received a high level of patient satisfaction. CARRYBOT, patient transfer robot that assists caregivers to move patients comfortably and safely proved its credentials of reducing muscle use of patients when they are transferred with the machine. HHI also started clinical trials of ROBIN, a robot system that guides needle path in CT-guided interventional procedure, at Asan Medical Center and Ulsan University Hospital with the goal of establishing liver cancer treatment methodology and lung tissue test.

HHI plans to export the three medical robots from the second half of 2017 on the basis of track records accumulated from these clinical trials.